Australia's largest stock trading and investment forum Australia's #1 stock forum

NEURIZON THERAPEUTICS LIMITED

4.76%

11.0¢

Market Cap $54.15M

Healthcare Biotechnology

Neurizon Therapeutics Limited (ASX: NUZ) is a clinical-stage biotechnology company... Neurizon Therapeutics Limited (ASX: NUZ) is a clinical-stage biotechnology company dedicated to advancing treatments for neurodegenerative diseases. Neurizon is developing its lead drug candidate, NUZ-001, for the treatment of ALS, which is the most common form of motor neurone disease. Neurizon's strategy is to accelerate access to effective ALS treatments for patients, while exploring NUZ-001’s potential for broader neurodegenerative applications.More

Corporate Spotlight

Neurizon Therapeutics Limited (ASX: NUZ) is a clinical-stage biotechnology company dedicated to advancing treatments for neurodegenerative diseases. Neurizon is developing its lead drug candidate, NUZ-001, for the treatment of ALS, which is the most common form of motor neurone disease.
View the full Corporate Spotlight

NUZ LATEST INTERVIEW WITH CEO & MD MICHAEL THURN

Latest Threads

Tag

Subject

NUZ -- New Investor thread

14 15 16

16/03/25

915

273K

16/03/25

Last post Quiltman

915

273K

Ann: Neurizon updates on NUZ-001 IND Application

6 7 8

14/03/25

433

125K

14/03/25

Last post Peeteepoo

433

125K

Strathmin2 the Holy Grail or cream on the cake?

06/03/25

11

4.0K

06/03/25

Last post Quiltman

11

4.0K

TOP 100 NUZ HOLDERS 28/02/2025

04/03/25

5

1.9K

04/03/25

Last post unbiased

5

1.9K

TOP 100 NUZOA HOLDERS AS AT 30/04/2026

02/03/25

0

407

02/03/25

Last post RAN58

0

407

MND surveillance centre

23/02/25

1

583

23/02/25

Last post Scottyhilux

1

583

Ann: Neurizon to Present Latest Results and Key Updates

2

21/02/25

102

24K

21/02/25

Last post Quiltman

102

24K

Ann: FDA Guidance on NUZ-001 IND Application

2

20/02/25

101

24K

20/02/25

Last post Quiltman

101

24K

Neurozon to Present Latest Results and updates

18/02/25

0

332

18/02/25

Last post rons1310

0

332

Ann: Appendix 4D - Half-year Financial Report - 31 December 2024

14:48

0

537

14:48

Last post

ASX News

0

537

Ann: US Patent granted for NUZ-001

13/02/25

57

21K

13/02/25

Last post Dryasachip

57

21K

Ann: Notice of Company Update Webinar

13/02/25

11

3.6K

13/02/25

Last post Peeteepoo

11

3.6K

[INTERVIEW] Neurizon granted US patent for NUZ-001

10/02/25

18

4.9K

10/02/25

Last post TheBrownHornet

18

4.9K

Full takeover versus multiple deals?

2

07/02/25

103

23K

07/02/25

Last post Icebluedenim

103

23K

Ann: Change of Director's Interest Notices x3

07/02/25

9

2.1K

07/02/25

Last post Dryasachip

9

2.1K

Pharmaust - Media & News

4 5 6

05/02/25

350

125K

05/02/25

Last post Grainofsand

350

125K

See All Discussions

Corporate Spotlight

ABOUT NEURIZON

Timeline

Appendix 4D - Half-year Financial Report - 31 December 2024
17 Feb 14:28	Share

Neurizon to Present Latest Results and Key Updates
17 Feb 09:27	Share

FDA Guidance on NUZ-001 IND Application
17 Feb 09:14	Share

Notice of Company Update Webinar
11 Feb 14:29	Share

Change of Director's Interest Notices x3
07 Feb 09:58	Share

US Patent granted for NUZ-001
05 Feb 09:18	Share

Notification regarding unquoted securities - NUZ
31 Jan 16:46	Share

Appendix 4C & Quarterly Update
29 Jan 09:14	Share

Neurizon updates on NUZ-001 IND Application
17 Jan 09:59	Share

Change of Share Registry
16 Jan 08:19	Share

Section 708A Cleansing Statement
27 Dec 17:07	Share

Application for quotation of securities - NUZ
27 Dec 17:00	Share

Neurizon Files IND Application to Support HEALEY ALS Trial
18 Dec 09:13	Share

Neurizon Granted OMPD for NUZ-001 in Europe
17 Dec 08:52	Share

Positive 8-month Interim Data from OLE Study
16 Dec 09:34	Share

Neurizon Presents Company Update and 2025 Outlook
12 Dec 15:08	Share

Neurizon Receives Additional R&D Tax Incentive Rebate
11 Dec 13:47	Share

Notice of Company Update Webinar
05 Dec 09:29	Share

Section 708A Cleansing Statement
29 Nov 16:17	Share

Application for quotation of securities - NUZ
29 Nov 16:06	Share

Updated Securities Trading Policy
19 Nov 12:13	Share

Correction to text positioning error in announcement
15 Nov 18:30	Share

Neurizon Presents Positive Preclinical Data on NUZ-001
15 Nov 09:59	Share

NUZ-001 Reduces Aggregation of Key ALS Disease Target
15 Nov 09:50	Share

Positive opinion received on OMPD for NUZ-001 in Europe
11 Nov 09:39	Share

Change of Director's Interest Notices x4
08 Nov 10:09	Share

Notification regarding unquoted securities - NUZ
07 Nov 15:02	Share

Notification regarding unquoted securities - NUZ
07 Nov 15:02	Share

Notification regarding unquoted securities - NUZ
07 Nov 14:36	Share

Section 708A Cleansing Statement
01 Nov 15:19	Share

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 11.0¢		Change 0.005(4.76%)		Mkt cap ! $54.15M

Open	High	Low	Value	Volume
11.0¢	11.5¢	11.0¢	$46.74K	420.2K

Buyers (Bids)

No.	Vol.	Price($)
3	90999	11.0¢

Sellers (Offers)

Price($)	Vol.	No.
11.5¢	118050	2

View Market Depth

No.	Vol.	Price($)
3	90999	0.110
7	151672	0.105
14	504762	0.100
2	301780	0.099
1	30622	0.097

Price($)	Vol.	No.
0.115	118050	2
0.120	170000	1
0.130	31962	2
0.135	21658	1
0.145	9370	2

Last trade - 16.10pm 14/03/2025 (20 minute delay)

NUZ (ASX) Chart

SPONSORED BY